3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
1006
Uterine Cervical Neoplasms
420
Endometrial Neoplasms
350
Carcinoma, Non-Small-Cell Lung
292
Breast Neoplasms
292
Neoplasms
238
Colorectal Neoplasms
233
Fallopian Tube Neoplasms
211
Stomach Neoplasms
192
Pancreatic Neoplasms
184
Melanoma
157
Prostatic Neoplasms
152
Triple Negative Breast Neoplasms
148
Carcinoma, Ovarian Epithelial
147
Lung Neoplasms
136
Neoplasm Metastasis
133
Squamous Cell Carcinoma of Head and Neck
131
Carcinoma, Renal Cell
130
Head and Neck Neoplasms
122
Esophageal Neoplasms
121
Urinary Bladder Neoplasms
112
Small Cell Lung Carcinoma
90
Sarcoma
80
Carcinoma, Hepatocellular
76
Recurrence
70
Carcinoma, Transitional Cell
70
Uterine Cervical Dysplasia
66
Papillomavirus Infections
66
Colonic Neoplasms
59
Cholangiocarcinoma
59
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pancreatic Intraductal Neoplasms
×
Gynecologic
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled